117 related articles for article (PubMed ID: 31494965)
1. Immunosuppression reduction in kidney transplant recipients during bacterial infection-A retrospective study.
Yahav D; Sulimani O; Green H; Margalit I; Ben-Zvi H; Mor E; Rozen-Zvi B
Clin Transplant; 2019 Oct; 33(10):e13707. PubMed ID: 31494965
[TBL] [Abstract][Full Text] [Related]
2. Randomized controlled trial assessing the impact of everolimus and low-exposure tacrolimus on graft outcomes in kidney transplant recipients.
Taber DJ; Chokkalingam A; Su Z; Self S; Miller D; Srinivas T
Clin Transplant; 2019 Oct; 33(10):e13679. PubMed ID: 31365151
[TBL] [Abstract][Full Text] [Related]
3. How does age affect the outcome of kidney transplantation in elderly recipients?
Neri F; Furian L; Cavallin F; Ravaioli M; Silvestre C; Donato P; La Manna G; Pinna AD; Rigotti P
Clin Transplant; 2017 Oct; 31(10):. PubMed ID: 28640530
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D as a risk factor for patient survival after kidney transplantation: A prospective observational cohort study.
Thorsen IS; Bleskestad IH; Åsberg A; Hartmann A; Skadberg Ø; Brede C; Ueland T; Pasch A; Reisaeter AV; Gøransson LG
Clin Transplant; 2019 May; 33(5):e13517. PubMed ID: 30844090
[TBL] [Abstract][Full Text] [Related]
5. Metformin use in the first year after kidney transplant, correlates, and associated outcomes in diabetic transplant recipients: A retrospective analysis of integrated registry and pharmacy claims data.
Vest LS; Koraishy FM; Zhang Z; Lam NN; Schnitzler MA; Dharnidharka VR; Axelrod D; Naik AS; Alhamad TA; Kasiske BL; Hess GP; Lentine KL
Clin Transplant; 2018 Aug; 32(8):e13302. PubMed ID: 29851159
[TBL] [Abstract][Full Text] [Related]
6. Safety and Efficacy Outcomes 3 Years After Switching to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: Results From a Phase 2 Randomized Trial.
Grinyó JM; Del Carmen Rial M; Alberu J; Steinberg SM; Manfro RC; Nainan G; Vincenti F; Jones-Burton C; Kamar N
Am J Kidney Dis; 2017 May; 69(5):587-594. PubMed ID: 27889299
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Renal Function in Liver Transplant Recipients After Conversion From Calcineurin Inhibitors to mTOR Inhibitors.
Hüsing A; Schmidt M; Beckebaum S; Cicinnati VR; Koch R; Thölking G; Stella J; Heinzow H; Schmidt HH; Kabar I
Ann Transplant; 2015 Nov; 20():707-13. PubMed ID: 26608590
[TBL] [Abstract][Full Text] [Related]
8. Conversion to everolimus in kidney transplant recipients: to believe or not believe?
Cotovio P; Neves M; Santos L; Macário F; Alves R; Mota A
Transplant Proc; 2012 Dec; 44(10):2966-70. PubMed ID: 23195007
[TBL] [Abstract][Full Text] [Related]
9. Increased Mortality and Graft Loss With Kidney Retransplantation Among Human Immunodeficiency Virus (HIV)-Infected Recipients.
Shelton BA; Mehta S; Sawinski D; Reed RD; MacLennan PA; Gustafson S; Segev DL; Locke JE
Am J Transplant; 2017 Jan; 17(1):173-179. PubMed ID: 27305590
[TBL] [Abstract][Full Text] [Related]
10. Calcineurin inhibitor- and corticosteroid-free immunosuppression in pediatric heart transplant patients.
Sierra CM; Tan R; Eguchi J; Bailey L; Chinnock RE
Pediatr Transplant; 2017 Feb; 21(1):. PubMed ID: 27658616
[TBL] [Abstract][Full Text] [Related]
11. The epidemiology of Clostridium difficile infection in a national kidney transplant center.
Kennedy C; Waldron C; Skally M; Gaughan L; Magee C; Burns K; Fitzpatrick F
Clin Transplant; 2017 Jun; 31(6):. PubMed ID: 28295646
[TBL] [Abstract][Full Text] [Related]
12. Belatacept Rescue Therapy in Kidney Transplant Recipients With Vascular Lesions: A Case Control Study.
Bertrand D; Cheddani L; Etienne I; François A; Hanoy M; Laurent C; Lebourg L; Le Roy F; Lelandais L; Loron MC; Godin M; Guerrot D
Am J Transplant; 2017 Nov; 17(11):2937-2944. PubMed ID: 28707779
[TBL] [Abstract][Full Text] [Related]
13. An mTOR-inhibitor-based protocol and calcineurin inhibitor (CNI)-free treatment in kidney transplant recipients from donors after cardiac death: good renal function, but high incidence of conversion to CNI.
Sánchez-Escuredo A; Diekmann F; Revuelta I; Esforzado N; Ricart MJ; Cofán F; Torregrosa JV; Peri L; Ruiz Á; Campistol JM; Oppenheimer F
Transpl Int; 2016 Mar; 29(3):362-8. PubMed ID: 26678359
[TBL] [Abstract][Full Text] [Related]
14. CNI withdrawal for post-transplant lymphoproliferative disorders in kidney transplant is an independent risk factor for graft failure and mortality.
Rabot N; Büchler M; Foucher Y; Moreau A; Debiais C; Machet MC; Kessler M; Morelon E; Thierry A; Legendre C; Rivalan J; Kamar N; Dantal J
Transpl Int; 2014 Sep; 27(9):956-65. PubMed ID: 24964147
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes in HIV+/HCV+ coinfected kidney transplant recipients in the pre- and post-direct-acting antiviral therapy eras: 10-Year single center experience.
Camargo JF; Anjan S; Chin-Beckford N; Morris MI; Abbo LM; Simkins J; Ciancio G; Chen LJ; Burke GW; Figueiro J; Guerra G; Kupin WL; Mattiazzi A; Ortigosa-Goggins M; Ram Bhamidimarri K; Roth D
Clin Transplant; 2019 May; 33(5):e13532. PubMed ID: 30866102
[TBL] [Abstract][Full Text] [Related]
16. Outcome of sirolimus-based immunosuppression, fifteen years post-live-donor kidney transplantation: Single-center experience.
Hamdy AF; Elhadedy MA; Donia AF; Taha NM; Bakr MA
Clin Transplant; 2019 Feb; 33(2):e13463. PubMed ID: 30548935
[TBL] [Abstract][Full Text] [Related]
17. Influence of patient characteristics and immunosuppressant management on mortality in kidney transplant recipients hospitalized with coronavirus disease 2019 (COVID-19).
Santeusanio AD; Menon MC; Liu C; Bhansali A; Patel N; Mahir F; Rana M; Tedla F; Mahamid A; Fenig Y; Zendel A; Delaney V; De Boccardo G; Farouk SS; Sehgal V; Khaim R; Jacobs SE; Dunn D; Sullivan T; Taimur S; Baneman E; Florman S; Shapiro R
Clin Transplant; 2021 Apr; 35(4):e14221. PubMed ID: 33421213
[TBL] [Abstract][Full Text] [Related]
18. Early steroid withdrawal results in improved patient and graft survival and lower risk of post-transplant cardiovascular risk profiles: A single-center 10-year experience.
Lopez-Soler RI; Chan R; Martinolich J; Park L; Ata A; Chandolias N; Conti DJ
Clin Transplant; 2017 Feb; 31(2):. PubMed ID: 27888534
[TBL] [Abstract][Full Text] [Related]
19. Renal transplantation in human immunodeficiency virus-infected recipients: a case-control study from the Brazilian experience.
Vicari AR; Spuldaro F; Sandes-Freitas TV; Cristelli MP; Requião-Moura LR; Reusing JO; Pierrotti LC; Oliveira ML; Girão CM; Gadonski G; Kroth LV; Deboni LM; Ferreira GF; Tedesco-Silva H; Esmeraldo R; David-Neto E; Saitovitch D; Keitel E; Garcia VD; Pacheco-Silva A; Medina-Pestana JO; Manfro RC
Transpl Infect Dis; 2016 Oct; 18(5):730-740. PubMed ID: 27503081
[TBL] [Abstract][Full Text] [Related]
20. Outcomes, complications, and economic impact of ABO-incompatible living kidney transplantation: A single-center Japanese cohort study.
Kakuta Y; Okumi M; Unagami K; Iizuka J; Takagi T; Ishida H; Tanabe K
Clin Transplant; 2019 Jun; 33(6):e13591. PubMed ID: 31077450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
